Haibin Luo

Publication Activity (10 Years)

Years Active: 2018-2021
Publications (10 Years): 3

Top Topics

Monoclonal Antibody

Tandem Mass Spectrometry

High Performance Liquid Chromatography

Top Venues

Biotechnology progress

AstraZeneca

This page only lists publications with an associated author ORCID identifier.

Affiliation History

AstraZeneca

United States

Scientist :: PPS

Publications

Haibin Luo, Yuling Li, David Robbins, Sheau-Chiann Wang, Guoling Xi, Matthew Cox, Simone M Nicholson, Chenghong Wei, Timothy M Pabst, William K Wang
Safety risk management for low molecular weight process-related impurities in monoclonal antibody therapeutics: Categorization, risk assessment, testing strategy, and process development with leveraging clearance potential. Biotechnology progress 37 (3) (2021)
Qun Du, Melissa M Damschroder, Timothy M Pabst, Alan K Hunter, William K Wang, Haibin Luo
Process optimization and protein engineering mitigated manufacturing challenges of a monoclonal antibody with liquid-liquid phase separation issue by disrupting inter-molecule electrostatic interactions. mAbs 11 (4) (2019)
Haibin Luo, Liu Tie, Mingyan Cao, Alan K Hunter, Timothy M Pabst, Jiali Du, Raymond Field, Yuling Li, William K Wang
Cathepsin L Causes Proteolytic Cleavage of Chinese-Hamster-Ovary Cell Expressed Proteins During Processing and Storage: Identification, Characterization, and Mitigation. Biotechnology progress 35 (1) (2018)